Fig. 1: Survival analysis between low and high plasma legumain group.

Kaplan–Meier estimates of all-cause mortality between AMI patients with low (≤10μg/L) and high (>10μg/L) plasma legumain levels.
Kaplan–Meier estimates of all-cause mortality between AMI patients with low (≤10μg/L) and high (>10μg/L) plasma legumain levels.